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Protein molecules, toxins and viruses internalize into the cell via receptor-mediated
endocytosis (RME) using specific proteins and lipids in the plasma membrane. The plasma
membrane is a barrier for many pharmaceutical agents to enter into the cytoplasm
of target cells. In the case of cancer cells, tissue-specific biomarkers in the plasma
membrane, like cancer-specific growth factor receptors, could be excellent candidates for
RME-dependent drug delivery. Recent data suggest that agent binding to these receptors
at the cell surface, resulting in membrane domain formation by receptor clustering, can be
used for the initiation of RME. As a result, these pharmaceutical agents are internalized
into the cells and follow different routes until they reach their final intracellular targets like
lysosomes or Golgi. We propose that clustering induced formation of plasma membrane
microdomains enriched in receptors, sphingolipids, and inositol lipids, leads to membrane
bending which functions as the onset of RME. In this review we will focus on the role of
domain formation in RME and discuss potential applications for targeted intracellular drug
delivery.
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INTRODUCTION
Receptor-mediated endocytosis (RME) is a way of internalization
of larger molecules, toxins and viruses into the cell using specific
proteins and lipids in the plasma membrane. Whereas a major-
ity of small molecules can diffuse through the plasma membrane
(PM), larger cargo needs energy-dependent assistance of both
proteins and lipids in the PM to get into the cell. Upon binding
of the ligand to the receptor on the cell surface, a signaling cas-
cade is activated, leading to the invagination of the membrane,
followed by the formation of the vesicle. The vesicle then pinches
of the membrane and, following one of the endocytic pathways,
gets transferred to a specific intracellular location.
Due to high specificity and efficiency, RME presents itself as an
excellent system for drug delivery of various therapeutical com-
pounds/agents. In cancer therapy, receptors used as targets for
different pharmaceutical agents comprise mostly receptor tyro-
sine kinases and the transferrin receptor, as these proteins are
overexpressed in a number of tumors (Zaki and Tirelli, 2010).
Other receptors that are investigated for targeted drug delivery,
albeit in a less extent, comprise vitamin receptors, like folate and
riboflavin receptors, lectin receptors, receptors for cell adhesion
molecules, etc.
Mechanistic details of receptor-mediated drug delivery are
studied mostly with a focus on the interaction between a receptor
and a corresponding ligand, as well as on the specific endocytic
pathway. Recently, more attention is being paid to the changes
in the lipid environment. The elucidation of this aspect of RME
is not only an important fundamental question but could also
improve drug delivery. The changes in the lipid environment
during RME refer not only to larger segments of PM that get inter-
nalized with ligand bound receptors, but also to the formation
of membrane domains of distinct features that are present in the
closest vicinity of the receptors.
DOMAINS IN THE PLASMAMEMBRANE
Plasma membrane (PM) is a dynamic mixture of proteins and
lipids that delineates the cell and enables the communication
with the environment. Proteins that function within PM are inte-
grated in or associated with the lipid bilayer composed of three
major classes of lipids: glycerophospholipids, sphingolipids, and
sterols (van Meer, 2005). Since Singer-Nicolson’s model of the
plasma membrane (Singer and Nicolson, 1972) our understand-
ing of the organization of PM and the regulation of its function
has drastically evolved (Engelman, 2005; Simons and Gerl, 2010;
Kusumi et al., 2012). The plasma membrane is no longer depicted
as a fluid lipid carpet with mosaically distributed proteins asso-
ciated with or spanning the lipid bilayer. Instead, the plasma
membrane can be seen more as a city map where protein-lipid
ensembles of specific localization, size and orientation are non-
homogenously distributed in distinct regions, often termed as
membrane domains. The membrane domain should therefore be
understood as a general term comprising various suborganellar
constructions of distinct features found in the membrane.
These non-homogenously distributed ensembles of the plasma
membrane are found in membranes of a number of organ-
isms including bacteria (Maddock and Shapiro, 1993), yeast
(Malínská et al., 2003), and in a range of mammalian cells, includ-
ing cancer cells (Staubach and Hanisch, 2011; George and Wu,
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2012). Ergosterol rich microcompartment of Can1 (MCC) in
S. cerevisiae was shown to be composed of specific lipids, being
enriched in ergosterol in particular, and relatively a well-defined
protein content of at least 21 proteins (Grossmann et al., 2007,
2008). The MCC proteins are rarely found in the other mem-
brane microdomain, the microcompartment of Pma1 (MCP).
Both MCC and MCP are relatively large (over 300 nm), and can
be studied using various methods of optical microscopy. Analysis
of MCC using electron microscopy revealed that MCC are struc-
turally organized into furrow-like invaginations (Stradalova et al.,
2009). This structure is maintained by BAR domain proteins Pil1
and Lsp1 (Ziółkowska et al., 2011). These banana-shaped proteins
associate with the PM on the cytosolic side inducing a geometrical
curvature of the membrane.
Lipid rafts in mammalian cells are still a matter of controversy.
They were initially identified as cholesterol and sphingolipids-
enriched microdomains found in detergent insoluble membrane
fractions. It was shown that these fractions contain increased lev-
els of glycophosphatidylinositol-anchored proteins and a number
of signaling molecules suggesting that rafts play significant roles
in immunity, signaling, organization of cytoskeleton, etc. (Brown
and Rose, 1992; Simons and Ikonen, 1997; Simons and Toomre,
2000; Harris and Siu, 2002). The existence of lipid rafts was, how-
ever, difficult to be proven in vivo. Detergent extraction that was
used to prove the existence of lipid rafts could not be standard-
ized and the results obtained by different groups showed large
variations (Munro, 2003). With the development of novel tech-
niques, like super resolution light microscopy and fluorescence
resonance energy transfer (FRET), nanoclusters containing raft
proteins were shown to exist in vivo, yet the detailed mechanism
of their formation and the exact role in different cellular processes
is still being investigated (Lingwood and Simons, 2009; Simons
and Gerl, 2010).
Lipid raft proteins and lipids are present in the vesicles of
distinct endocytic pathways. Clathrin independent endocytosis
(CIE) occurs mostly via formation of lipid rafts (Hansen and
Nichols, 2009; El-Sayed and Harashima, 2013). For example,
caveolae-mediated endocytosis, a type of CIE, requires direct
interaction between protein caveolin and cholesterol in the lipid
rafts for the formation of the vesicles (Murata et al., 1995; Smart
et al., 1999). Conversely, clathrin-mediated endocytosis (CME)
does not appear to be initiated within the lipid rafts, as the former
do not enter clathrin-coated pits (Nichols, 2003).
In addition to lipid rafts, another type of membrane domain
was suggested to exist in the PM. Already during 1970s, it
was observed that the proteins and lipids diffuse much slower
(up to 20 times) in vivo than in artificial membranes (Axelrod
et al., 1976; Baier et al., 2009). In erythrocyte cells lacking the
spectrin-based cortical network an increase in diffusion coeffi-
cient of a membrane protein was reported (Sheetz et al., 1980).
Studying the trajectories of individual molecules using single par-
ticle tracking demonstrated that several proteins from the PM
diffuse within a confined moving surface (Kusumi et al., 1993). In
kidney cells with disrupted cytoskeleton, the confinement space
and the diffusion rates of membrane proteins were shown to
be increased (Sako and Kusumi, 1995). Diffusion rates of phos-
pholipids increased up to nine-fold when actin filaments were
obstructed (Fujiwara et al., 2002). It is hypothesized that actin
forms amembrane skeleton on the cytosolic side of PM that inter-
acts with integrated membrane proteins and forms membrane
compartments of the size of 40–300 nm (Kusumi et al., 2012).
Different membrane microdomains containing various com-
binations of membrane proteins and lipids have been identified
throughout the years. These domains do not necessarily fit the
definition of either rafts or actin restricted membrane compart-
ments. They are more or less transient and of various sizes, and
are characterized based on the interactions between proteins and
lipids. In addition, novel types ofmicrodomains are generated as a
response to exogenous and endogenous signals. An example could
be the formation of microdomains consisting of peptide-lipid
complexes of highmolecular weight as a reaction to increased lev-
els of human islet amyloid polypeptide during the development of
diabetes type II (Guo et al., 2014).
To get a full understanding of such a diversity of membrane
microdomains and a complex function of the PM one must take
into account biophysical features of both proteins and lipids.
On the one hand, specific protein localization and confinement
depend on lipid composition and distribution. On the other
hand, lipid moiety influences the function of proteins through
several biophysical parameters like the charge of lipid polar heads
(Kalli et al., 2013) and membrane voltage (Bezanilla, 2008), as
well as steric effects. Latter effects are exerted by individual lipid
molecules, particularly cholesterol and ergosterol, in mammalian
and yeast cells, respectively (Sheets et al., 1999; Kwik et al., 2003).
In a more general manner, steric effects are exerted through
the geometrical changes of membrane curvature. Regions in the
plasma membrane with different curvatures have different pro-
tein and lipid composition. Changes in geometrical membrane
curvature were suggested to play a role in regulating the func-
tion and distribution of both proteins and lipids (Sorre et al.,
2009; Henne et al., 2010; Antonny, 2011; Domanov et al., 2011;
Tonnesen et al., 2014). The occurrence of a very fast bending of
themembrane during RME could therefore play a role in dynamic
regulation of transmembrane protein function. This speculation
still needs to be investigated.
EGFR AS A MODEL FOR THE MECHANISM OF THE RECEPTOR
CLUSTERING
The organization of the PM in a number of essential cellular
processes is studied using a number of different well-defined pro-
teins and lipids. Receptor tyrosine kinases (RTK) are often used as
model proteins for studying receptor clustering and the formation
of membrane domains. The epidermal growth factor receptor
(EGFR) belongs to ErbB family of RTK and is a crucial member
of signaling networks regulating cell proliferation. Other mem-
bers of ErbB family are HER2-4. Themechanisms and the biology
of ErbB proteins are complex; there are 11 different growth fac-
tors serving as ligands for 4 ErbB receptors (Linggi and Carpenter,
2006). ErbB proteins are crucial in the embryonic stage for the
development of nervous system, and necessary for normal heart
function (Lemmon et al., 2014). All members of ErbB family are
involved with the development of different types of cancer and
were successfully used as targets in cancer therapy (Arteaga and
Engelman, 2014).
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EGFR is a single transmembrane domain with N-terminus
exposed to the extracellular matrix and a C-terminus with a
kinase domain exposed to cytoplasm (Jorissen et al., 2003). The
N-terminal part of EGFR consists of four domains involved in lig-
and binding and receptor dimerization. Ligand binding to EGFR
leads to receptor dimerization and transphosphorylation, as well
as to the formation of receptor clusters (Clayton, 2005; Saffarian
et al., 2007). Receptor clustering within a specific membrane
domain is crucial in several signaling pathways (Minguet et al.,
2007; Nikolaev et al., 2010). Receptor clustering that occurs upon
binding of EGF to EGFR depends on its kinase activity (Hofman
et al., 2010). Moreover, EGF was shown to induce the formation
of EGFR nanoclusters depending on the activity of phospholipase
D2 (Ariotti et al., 2010). Upon its activation, EGFR is quickly
internalized (see Figure 1). After internalization and endosomal
sorting EGFR is either degraded in lysosomes or recycled back to
PM (Sorkin and Goh, 2009). Under physiological concentrations
of ligand, the internalization of EGFR occurs mainly via CME.
In the presence of increased levels of EGF and the overexpres-
sion of EGFR, the ubiquitination of the receptor is increased and
the internalization occurs via CIE to a larger extent (Carpentier
et al., 1982; Wiley, 1988; Sigismund et al., 2005). CIE appears to
be a default pathway for the degradation of EGFR whereas CME
mostly leads to recycling of EGFR into the PM (Sigismund et al.,
2008).
According to crystal structures the extracellular part of
EGFR is responsible for EGFR dimerization (Ferguson, 2008).
Dimerization of EGFR is also regulated by its transmembrane
domain, as this domain contains two GxxxG dimerization motifs,
one closer to N terminus, and one closer to the C termi-
nus. Molecular dynamics (MD) simulations suggest that in
ligand-bound dimers, conformational changes of the extracel-
lular domains favor dimerization of the transmembrane helices
near their N termini (Arkhipov et al., 2013). Site specific cystein
crosslinking studies showed that crosslinks could be made within
the N-terminal GxxxG motif (Lu et al., 2010). The N-terminal
GxxxG dimerizationmotif was found to be essential for clustering
induced internalization (Heukers et al., 2013).
In reconstitution studies it was shown that cholesterol pre-
dominantly stabilizes the dimerization of the N-terminal GxxxG
motif (Jones et al., 1997).We favor themodel where the formation
of EGFR clusters results in the assembly of ganglioside GM1 and
cholesterol enriched membrane domains. This stabilizes the for-
mation of N-terminal transmembrane domain dimers, resulting
in the bending of the membrane. As a result, local lipid pressure
is reduced inviting the insertion of proteins with a BAR domain.
FIGURE 1 | Trafficking of activated EGFR. EGFR clustering occurs upon
activation by EGF, followed by internalization via both clathrin-mediated and
clathrin independent endocytosis, CME and CIE, respectively. This leads to
formation of signaling endosomes that fuse into early endosomes and
multivesicular bodies (MVB). Second type of EGFR internalization occurs in
MVBs via ESCRT complex.
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The F-BAR domain proteins, such as FCH01/2, are among the
first proteins that are recruited to the curved membrane, the
site in the membrane where receptor internalization is initiated
(Henne et al., 2010; McMahon and Boucrot, 2011; Taylor et al.,
2011). Models of mechanisms of membrane domain formation
and subsequent membrane curvature formation as the effect of
specific protein clustering were suggested for several proteins.
The most prominent example is the binding and internaliza-
tion of Shiga toxin from Shigella dysenteriae. Association of Shiga
toxin, with its glycolipid receptor leads to the formation of clus-
ters that induce negative curvature on the membrane, resulting
in the formation of narrow invaginations (Römer et al., 2007).
Shiga toxin consists of two subunits, where the bigger one has
homopentameric structure. Similar models where pentameric
protein scaffolds together with glycosphingolipids like ganglio-
side GM1 induce plasma membrane curvature, followed by the
endocytic uptake into cells, were also proposed for some viruses,
like SV40 and norovirus (Ewers et al., 2009; Rydell et al., 2013).
In addition, similarities between EGFR clustering model and the
model of formation of MCC in yeast (Douglas et al., 2011) are
more than evident.
EGFR CLUSTERING AND CANCER THERAPY
Understanding the detailed mechanism of EGFR internalization
is crucial regarding the connection of EGFR and cancer. Mutant
forms and pathologically increased expression levels of EGFR
and other members of ErbB family, HER2, ErbB3, and ErbB4
are implicated in cancer initiation and development. Thirty years
ago mutant forms of EGFR and HER2 were linked to cancer
cells in chicken and rat, respectively (Downward et al., 1984;
Schechter et al., 1984). The evidence for the connection between
ErbB family members and different forms of cancer, accumulated
over the years, led to the development of different agents for the
inhibition of EGFR as anti-cancer drugs (Cancer Genome Atlas
Network, 2012; Lemmon et al., 2014). Inhibitors of ErbB fam-
ily receptors have proven to be rather successful agents in cancer
therapy. They include monoclonal antibodies (mAbs) like cetux-
imab (anti-EGFR) or trastuzumab (anti-HER2), small molecules
that are inhibitors of kinase activity (lapatinib), or antibody-drug
conjugates (Oliveira et al., 2006; Arteaga and Engelman, 2014).
Cetuximab binds to EGFR with higher affinity than EGF and
induces internalization and degradation of the receptor. However,
as cancer cells quickly adapt and become resistant to Cetuximab
therapy, combination therapies that would be tailored to individ-
ual patients are proposed as a novel strategy for the treatment of
EGFR-driven cancers (Arteaga and Engelman, 2014). One exam-
ple is the targeting of multiple epitopes on EGFR simultaneously.
Sym004, the mixture of two monoclonal anti-EGFR antibodies,
induced removal of the receptor from the cancer cell surface
by triggering EGFR internalization and degradation, and was
effective in treatment of Cetuximab-resistant tumors (Pedersen
et al., 2010; Iida et al., 2013). Triepitopic fusion protein was also
shown to overcome acquired resistance to Cetuximab (Spangler
et al., 2012). In addition, antibodies against EGFR conjugated to
nanoparticles or liposomes carrying cytotoxic agents have been
used for targeted drug delivery. Liposomes containing doxoru-
bicin and conjugated on the surface with anti-EGFR antibody and
folic acid targeted both EGFR and folate receptor with enhanced
selectivity and reduced toxicity to healthy cells when compared to
liposomes targeted to a single receptor (Saul et al., 2006).
In constant pursuit of more efficient agents for cancer detec-
tion and treatment novel approaches are being investigated. One
example are nanobodies, variable domains of the heavy chain-
only antibodies found in camels, lamas, alpacas and certain
species of sharks (Hamers-Casterman et al., 1993). Nanobodies
are 10 times smaller than antibodies, yet having strong and spe-
cific binding comparable to those of conventional antibodies.
Nanobodies against EGFR developed in our group have shown
several advantages in cancer detection when compared to mAbs
(Oliveira et al., 2012, 2013). The accumulation in tumor was
faster and distribution was more homogeneous, with a more
rapid clearance of unbound molecules. Similar to mAb therapy,
nanobody-drug conjugates are being developed for efficient drug
delivery. First experiments with biparatopic nanobody that binds
two different epitopes on EGFR, showed the induction of EGFR
clusters in the plasma membrane, leading to the kinase inde-
pendent internalization. This clustering induced internalization
was completely dependent on the presence of the N-terminal
dimerization motif. This is in agreement with the abovemen-
tioned model of interdependence between EGFR clustering and
membrane microdomain formation. When these internalizing
nanobodies were conjugated to a photosensitizer a higher toxi-
city was observed when compared to a conjugate consisting of a
non-internalizing nanobody (Heukers et al., 2014). These results
clearly showed the advantage of using internalizing nanobodies
for the intracellular delivery of toxic compounds into cancer cells.
CONCLUSIVE REMARKS
The majority of studies on protein lipid interactions were per-
formed in artificial membranes in vitro and with MD simulations
in silico. Tackling the questions connected to the topic using
experiments in vivo have proven to be quite challenging and not
rarely a subject of controversy. This refers in particular on the def-
inition of membrane rafts. Novel single molecule methods enable
studying various processes associated with PM in vivo. Alongside
the development of technology and computer algorithms that
allow observing dynamic process on the PM of living cells in
high resolution, adequate model proteins and model lipids are
being tested. Studying activation, clustering, internalization and
trafficking of EGFR is a model system that allows us to tackle fun-
damental questions regarding lateral organization of lipids and
proteins into membrane domains, as well as their structural and
functional features.
Development of agents that would affect receptor clustering,
either on the level of the receptor, or on the level of the organiza-
tion of lipids in the membrane domain, was suggested as a novel
approach in receptor targeting for therapeutic purposes (Bethani
et al., 2010). Understanding the detailed mechanism of protein
lipid interdependence during EGFR clustering is an example of
a beautiful overlap of the fundamental and the pharmaceutical
research.With the elucidation of this mechanism,more principles
in the organization of the plasma membrane will be understood.
These principles could further on be tested on other cell types
as well as other organisms. At the same time, establishing exact
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mechanism and common principles of receptor clustering as
onset of RME would be crucial in further development of ways
of targeting and specific delivery of pharmaceutical agents.
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